Navigation Links
Drug Tarceva for End-stage Lung cancer

Patients with end-stage lung cancer who were given Tarceva lived longer than patients// given a placebo.

Lung cancer is the most common cancer occurring both in men and women. Two studies were conducted by Canadian –led international research team with recruits from all over the world.

The first study was conducted by Dr. Timothy Winton of the University of Alberta conducted his study in 482 patients. The study was done to prove that if chemotherapy is given to lung cancer patients after surgery, the survival rate of these patients is high. Surgeries prior to chemotherapy improved cure rate, 69% of the recruits are still alive five years later, compared with 54% who just had surgery. Overall, survival rate was 94 months for the study recruits compared to 73 months for those who had surgery alone.

A new drug Tarceva, generically know as erlotinib has undergone a phase 3 trial in patients with end-stage lung cancer, the study was conducted by researchers at Princess Margaret Hospital in Toronto and the results were published in New England Journal of Medicine, the study recruited 731 patients from around the world 488 patients received Tarceva and 243 patients were given a placebo. Patients who took Tarceva survived an average of 6.7 months, while placebo patients survived an average of 4.7 months. Though, the average months seem to be low, but you have to understand that Tarceva is given to end-stage lung cancer patients, who have no other chemotherapy options. It should also be noted that up to 15 % of patients lived longer than 2 years on the drug, compared to no one lived longer than 2 years taking placebo.

Though the figures are not so impressive we have to think this drug as a prospective drug as has an effective drug for treating early-stage lung cancer as it easy to cure compared to end-stage lung cancer.

Tarceva is one of the new class of drug that slows down tumor growth by arresting the specific cellular pathwa y that regulates the cell division. Dosage is 1 pill once a day. Tarceva not only increased the survival rate but also had no side effects and improved the quality of life. Patients taking Tarceva had only little symptoms of pain, shortness of breath and coughing, rash and diarrhea which can be easily managed.

“This is very significant because this is the first time that any treatment has been shown to prolong survival for patients with lung cancer after they've failed chemotherapy,” Dr. Shepherd said.

The drug has not yet been approved for use in Canada but was authorized for routine use in patients with advanced lung cancer by the U.S. Food and Drug Administration
'"/>




Related medicine news :

1. Tarceva Found To Benefit Older Lung Cancer Patients
2. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
3. Dialysis Trust Set Up in Bangalore by End-stage Kidney Patients
4. Vitamin B12 can help in detecting cancers
5. Want skin cancer? Please have a cigarette
6. New hope for cancer victims – will vaccine cure the deadly bug
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. Are cancer patients being taken for a ride?
9. Breast cancer treatment to be determined by gene test
10. Ductal lavage may detect early breast cancer
11. Beware of the oral patch! It could be cancer!!!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
(Date:8/18/2017)... ... August 18, 2017 , ... 800response, the leading ... solutions, announced today the launch of a redesigned corporate website, 800response.com . ... fully responsive design, and an enhanced search directory for businesses and advertising agencies ...
(Date:8/18/2017)... ... ... “Three Narrow Roads”: a vivid and provocative look into the narrow path toward ... Sr., is currently the pastor-teacher-visionary at Simply the WORD Church, a global prayer ministry ... program geared towards youth. , King shares, “When I take time to think about ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and marketers of high-quality anti-aging skincare solutions, recently announced the launch ... new products are an affordable, yet effective alternative to expensive plastic surgery or ...
(Date:8/18/2017)... ... ... “Steve the Snake”: an entertaining and moral-based short story about an unkind snake ... Flash Haskins Jr., a husband, father and grandfather who served as a U.S. Marine, ... short stories for children and teens. My goal is to teach kids to use ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... July 31, 2017 7D Surgical, developer of ground ... purchased the 7D Surgical System to support its strategic sales ... D.C. and Virginia.  7D Surgical has entered into ... of the premier medical facilities within those markets. ... ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
(Date:7/26/2017)... a leading medical aesthetic clinic in Singapore ... conditions from the inside. The natural process of aging ... becomes more transparent due to the thinning of the epidermis. Over the ... sun contributes to aging skin, causing age spots and other types ... ...
Breaking Medicine Technology: